XtalPi获得利物浦CHIChem, 藉由AI科技促进新药物和材料发现。 XtalPi acquires Liverpool ChiroChem to boost new drug and material discoveries with AI tech.

作为生命科学和新材料研发领域的领导者,XtalPi收购了利物浦奇罗化学 (LCC),这是一家自动化化学专家. XtalPi, a leader in life sciences and new materials R&D, has acquired Liverpool ChiroChem (LCC), a specialist in automated chiral chemistry. 合并的目的是通过将LCC的人工化学专门知识与XtalPi的人工智能和机器人技术相结合,加速发现新的药品和材料。 This merger aims to accelerate the discovery of new pharmaceuticals and materials by combining LCC's chiral chemistry expertise with XtalPi's AI and robotics technology. 扩大后的公司现在在美国、欧洲和亚洲有业务,向客户提供更大的灵活性和安全性。 The expanded company now has operations in the US, Europe, and Asia, offering clients enhanced flexibility and security.